THROMBOCYTOPENIA IN PROLONGED CHLORPROMAZINE THERAPY
Abstract
Two hundred and forty-five patients who had been on chlorpromazine medication for two or more years were evaluated hematologically, including platelet estimations. Only one case was found with a relatively low platelet count coincidental with leukopenia in which no interference in bleeding or clotting mechanism could be demonstrated. From our study we conclude that the development of thrombocytopenia in patients who are on prolonged therapy with chlorpromazine is rare. We plan to evaluate the 245 patients in this study at yearly intervals.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
